XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating Expenses:        
Research and development $ 1,092,665 $ 633,241 $ 2,063,480 $ 1,337,025
General and administration expenses 766,513 524,100 1,669,910 958,556
Total operating expenses 1,859,178 1,157,341 3,733,390 2,295,581
Loss from operations (1,859,178) (1,157,341) (3,733,390) (2,295,581)
Other Income (Expenses):        
Interest income 49 9,775 104 25,817
Loss before income taxes (1,859,129) (1,147,566) (3,733,286) (2,269,764)
Provision for income taxes 1,600 0 1,600 0
Net loss $ (1,860,729) $ (1,147,566) $ (3,734,886) $ (2,269,764)
Net Loss Per Share:        
Basic and diluted $ (0.1) $ (0.06) $ (0.2) $ (0.13)
Weighted average number of shares used in computing basic and diluted net loss per share:        
Basic and diluted 18,600,158 17,870,261 18,469,805 17,855,343